+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Protagen AG - Product Pipeline Analysis, 2021 Update

  • PDF Icon

    Company Profile

  • 44 Pages
  • June 2021
  • GlobalData
  • ID: 5367312
Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa SSC, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyelitis optica, systemic lupus erythematosus, systemic sclerosis, multiple sclerosis and ankylosing spondylitis. Protagen’s technology comprise SeroTag, which enables differential diagnosis and patient stratification in various diseases. The company also develops companion diagnostics to pharmaceutical and biotechnology companies. The company partners with various educational organization and other healthcare companies. It markets its products through its network of distributors. Protagen is headquartered in Dortmund, Nordrhein-Westfalen, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Protagen AG
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date

Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Protagen AG Company Overview
  • Protagen AG Company Snapshot
  • Protagen AG Pipeline Products and Ongoing Clinical Trials Overview
  • Protagen AG - Pipeline Analysis Overview
  • Protagen AG - Key Facts
  • Protagen AG - Major Products and Services
  • Protagen AG Pipeline Products by Development Stage

Protagen AG Pipeline Products Overview
  • Diagnostic Assay - Alzheimer's Disease
  • Diagnostic Assay - Alzheimer's Disease Product Overview
  • Diagnostic Assay - Ankylosing Spondylitis
  • Diagnostic Assay - Ankylosing Spondylitis Product Overview
  • Diagnostic Assay - Breast Cancer
  • Diagnostic Assay - Breast Cancer Product Overview
  • Diagnostic Assay - Colon Cancer
  • Diagnostic Assay - Colon Cancer Product Overview
  • Diagnostic Assay - Juvenile Idiopathic Arthritis
  • Diagnostic Assay - Juvenile Idiopathic Arthritis Product Overview
  • Diagnostic Assay - Multiple Sclerosis
  • Diagnostic Assay - Multiple Sclerosis Product Overview
  • Diagnostic Assay - Neuromyelitis Optica
  • Diagnostic Assay - Neuromyelitis Optica Product Overview
  • Diagnostic Assay - Ovarian Cancer
  • Diagnostic Assay - Ovarian Cancer Product Overview
  • Diagnostic Assay - Pancreatic Cancer
  • Diagnostic Assay - Pancreatic Cancer Product Overview
  • Diagnostic Assay - Parkinson's Disease
  • Diagnostic Assay - Parkinson's Disease Product Overview
  • Diagnostic Assay - Prostate Cancer
  • Diagnostic Assay - Prostate Cancer Product Overview
  • Diagnostic Assay - Type 1 Diabetes
  • Diagnostic Assay - Type 1 Diabetes Product Overview
  • Multilisa SLE
  • Multilisa SLE Product Overview
  • Multiplex Assay - Autoimmune Disease
  • Multiplex Assay - Autoimmune Disease Product Overview
  • Multiplex Assay - Cancer
  • Multiplex Assay - Cancer Product Overview
  • NavigAID - Cancer
  • NavigAID - Cancer Product Overview
  • NavigAID - Rheumatoid Arthritis
  • NavigAID - Rheumatoid Arthritis Product Overview
  • NavigAID - Sjogren’s Syndrome
  • NavigAID - Sjogren’s Syndrome Product Overview
  • Protagen Diagnostic Assay - Endometriosis
  • Protagen Diagnostic Assay - Endometriosis Product Overview

Protagen AG - Key CompetitorsProtagen AG - Key Employees
Protagen AG - Locations and Subsidiaries
  • Head Office

Recent Developments
  • Protagen AG, Recent Developments
  • Dec 18, 2018: Protagen names Dr. Jessica Hassel to its Scientific Advisory Board
  • Apr 10, 2018: Gustave Roussy and Protagen Collaborate to Improve the Risk Profiling of Cancer Patients Undergoing Immunotherapy
  • Feb 02, 2017: Protagen join forces with the U.S. National Cancer Institute to answer pressing questions in immuno-oncology
  • Dec 15, 2016: PROTAGEN launches NavigAID assay to support clinical drug development for autoimmune diseases
  • Dec 13, 2016: PROTAGEN Launches NavigAID Assay to Support Clinical Drug Development for Autoimmune Diseases
  • Jul 20, 2016: Protagen Appoints Bernhard Kirschbaum as New Chairman and Oliver Schacht as New Board Member
  • Jun 15, 2016: Protagen announces CE Mark for its proprietary Multilisa BICD2 test for better diagnosis of Systemic Sclerosis
  • May 31, 2016: Protagen launches first CE marked diagnostic assay Multilisa Scl-70 for the diagnosis of Systemic Sclerosis
  • May 31, 2016: Protagen Launches First CE Marked Diagnostic Assay Multilisa CENP-B For The Diagnosis Of Systemic Sclerosis
  • Feb 11, 2016: Protagen supports novel route to serum based Prostate Cancer Diagnostics

Appendix
  • Methodology
  • About the Publisher

List of Tables
  • Protagen AG Pipeline Products and Ongoing Clinical Trials Overview
  • Protagen AG Pipeline Products by Equipment Type
  • Protagen AG Pipeline Products by Indication
  • Protagen AG, Key Facts
  • Protagen AG, Major Products and Services
  • Protagen AG Number of Pipeline Products by Development Stage
  • Protagen AG Pipeline Products Summary by Development Stage
  • Diagnostic Assay - Alzheimer's Disease - Product Status
  • Diagnostic Assay - Alzheimer's Disease - Product Description
  • Diagnostic Assay - Ankylosing Spondylitis - Product Status
  • Diagnostic Assay - Ankylosing Spondylitis - Product Description
  • Diagnostic Assay - Breast Cancer - Product Status
  • Diagnostic Assay - Breast Cancer - Product Description
  • Diagnostic Assay - Colon Cancer - Product Status
  • Diagnostic Assay - Colon Cancer - Product Description
  • Diagnostic Assay - Juvenile Idiopathic Arthritis - Product Status
  • Diagnostic Assay - Juvenile Idiopathic Arthritis - Product Description
  • Diagnostic Assay - Multiple Sclerosis - Product Status
  • Diagnostic Assay - Multiple Sclerosis - Product Description
  • Diagnostic Assay - Neuromyelitis Optica - Product Status
  • Diagnostic Assay - Neuromyelitis Optica - Product Description
  • Diagnostic Assay - Ovarian Cancer - Product Status
  • Diagnostic Assay - Ovarian Cancer - Product Description
  • Diagnostic Assay - Pancreatic Cancer - Product Status
  • Diagnostic Assay - Pancreatic Cancer - Product Description
  • Diagnostic Assay - Parkinson's Disease - Product Status
  • Diagnostic Assay - Parkinson's Disease - Product Description
  • Diagnostic Assay - Prostate Cancer - Product Status
  • Diagnostic Assay - Prostate Cancer - Product Description
  • Diagnostic Assay - Type 1 Diabetes - Product Status
  • Diagnostic Assay - Type 1 Diabetes - Product Description
  • Multilisa SLE - Product Status
  • Multilisa SLE - Product Description
  • Multiplex Assay - Autoimmune Disease - Product Status
  • Multiplex Assay - Autoimmune Disease - Product Description
  • Multiplex Assay - Cancer - Product Status
  • Multiplex Assay - Cancer - Product Description
  • NavigAID - Cancer - Product Status
  • NavigAID - Cancer - Product Description
  • NavigAID - Rheumatoid Arthritis - Product Status
  • NavigAID - Rheumatoid Arthritis - Product Description
  • NavigAID - Sjogren’s Syndrome - Product Status
  • NavigAID - Sjogren’s Syndrome - Product Description
  • Protagen Diagnostic Assay - Endometriosis - Product Status
  • Protagen Diagnostic Assay - Endometriosis - Product Description

Protagen AG, Key Employees
  • Glossary

List of Figures
  • Protagen AG Pipeline Products by Equipment Type
  • Protagen AG Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ACGT ProGenomics AG
  • Grifols Deutschland GmbH
  • Bioscientia Institut fur Medizinische Diagnostik GmbH